- AU$12.30m
- AU$11.33m
- AU$0.64m
Regeneus to be granted key Progenza patent in Europe
PRE_NR Ends: 09:07:03
Regeneus Company Update Investor Webcast Presentation
PRE_NR Ends: 09:27:39
Appendix 3Z Final Director's Interest Notice Dr Alan Dunton
Half-Year Results and Business Update
PRE_NR Ends: 16:17:51
PRE_NR Ends: 16:05:41
Appendix 4D and Half-Year Report
Regeneus Company Update Investor Webcast Notification
Resignation of Non Executive Director Dr Alan Dunton
Australia's Regeneus climbs on Japanese patent grant for stem cell tech Progenza
Brief: Regeneus Granted New Patent To Target Pain In Japan
PRE_NR Ends: 09:14:12
Regeneus to be granted new patent to target pain in Japan
Response to ASX Appendix 4C Query
PRE_NR Ends: 09:19:40
Clarification on Quarterly Activity Report and Appendix 4C
Appendix 4C - Quarterly Report